Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Rivaroxaban and Warfarin for Stroke Prevention in Multi-morbid Patients With Nonvalvular Atrial Fibrillation

NCT03374540 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03374540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03374540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Rivaroxaban and Warfarin for Stroke Prevention in Multi-morbid Patients With Nonvalvular Atrial Fibrillation
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
August 30, 2019
Enrollment
78,517 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonvalvular atrial fibrillation